{
    "title": "Roivant, Pfizer team up on inflammatory disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11490761/Roivant-Pfizer-launch-unit-develop-inflammatory-disease-drug.html",
    "date": "2022-12-01",
    "keywords": [
        "pfizer",
        "drug",
        "deal",
        "roivant",
        "company",
        "treatment",
        "bhanvi",
        "satija",
        "mandowara",
        "disease",
        "rvt3101",
        "stake",
        "risinger",
        "colitis",
        "etrasimod",
        "opportunity",
        "study",
        "inflammatory",
        "dec",
        "firm",
        "thursday",
        "bowel",
        "multibillion",
        "dollar",
        "market",
        "business",
        "majority",
        "interest",
        "development",
        "japan",
        "payment",
        "analyst",
        "david",
        "research",
        "spending",
        "blockbuster",
        "part",
        "arena",
        "latestage",
        "year",
        "midsingle",
        "digit",
        "royalty",
        "executive",
        "matt",
        "gline",
        "induction",
        "portion",
        "ongoing",
        "matter",
        "month",
        "unit",
        "option",
        "antibody",
        "therapy",
        "tl1a",
        "presence",
        "crohns",
        "brepocitinib",
        "exchange",
        "reporting",
        "khushi",
        "bengaluru",
        "editing",
        "dsilva",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}